(Q44303658)

1 December 2017

title

Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice (English)

1 reference

1 December 2017

0 references

Hirokazu Mizoguchi

1

1 reference

1 December 2017

Kuei-chun Hung

2

1 reference

1 December 2017

Randy Leitermann

3

1 reference

1 December 2017

Minoru Narita

4

1 reference

1 December 2017

Hiroshi Nagase

5

1 reference

1 December 2017

Tsutomu Suzuki

6

1 reference

1 December 2017

Leon F Tseng

7

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

European Journal of Pharmacology

1 December 2017

published in

1 reference

1 December 2017

volume

461

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

35-39

1 reference

Potent antinociceptive effects of TRK-820, a novel kappa-opioid receptor agonist

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901299-8

Characterization of the antinociceptive effects of TRK-820 in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901299-8

Cloning of a delta opioid receptor by functional expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901299-8

Blockade of morphine reward through the activation of kappa-opioid receptors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901299-8

The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901299-8

Activation of G-proteins in the mouse pons/medulla by beta-endorphin is mediated by the stimulation of mu- and putative epsilon-receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901299-8

Discovery of a structurally novel opioid kappa-agonist derived from 4,5-epoxymorphinan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901299-8

Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901299-8

Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901299-8

Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901299-8

The novel kappa-opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901299-8

The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901299-8

Cloning and functional comparison of kappa and delta opioid receptors from mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901299-8

10.1016/S0014-2999(03)01299-8

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference